Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Henry Boot announces sale of construction arm as interim profits jump

(Sharecast News) - Property developer Henry Boot has announced the sale of its loss-making construction business as it reported a big jump in revenues and a doubling of profits over the first half. The company is selling entire issued share capital of Henry Boot Construction (HBC) to HBC management - through a newly formed company PWS Construction - for £4m, funded by PWC via a vendor loan note issued by Henry Boot.

The deal, which Henry Boot said allows it to focus on the strategic priority areas of high quality land, prime property development and premium homes, comes at a price in excess of HBC's net assets, reducing the risk profile of the group and cutting headcount by 21%.

HBC made an operating loss of £2.7m in 2024, on revenues of £49.7m, but is expected to break even in 2025 following the appointment of a new management team.

The sale came as Henry Boot announced its interim results, which showed a 19% increase in revenues to £126.4m, driven by land and property disposals. Pre-tax profit surged to £7.8m from £3.7m the year before.

The company said that 80% of budgeted sales for 2025 have now been completed, exchanged or reserved.

The interim dividend by was raised by 5% to 3.24p.

"Operationally, we have had a solid first half, which is no mean feat in uncertain markets, but we are also making strong progress strategically," said chief executive Tim Roberts.

"With 80% of budgeted sales achieved, we have confidence of meeting full-year expectations, and we also have conviction that there are clear opportunities within our high quality portfolio to hit our medium term growth and return targets."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.